Bausch Health Cos Inc (NYSE: BHC) suffers from extremely meaningful negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, the stock fell on very heavy volume, and negative upside/downside volume developed.
Recent minimal negative changes in fundamentals have impacted Bausch Health Cos Inc (NYSE: BHC): significant quarterly earnings deceleration occurred.
The stock is currently unrated.
Current PriceTarget Research Rating
Bausch Health is currently unrated.
Recent Price Action
Bausch Health Cos Inc (NYSE: BHC) stock suffered a large decline of -8.9% on 12/11/24. The stock closed at $7.58. Moreover, this decline was accompanied by exceptionally high trading volume at 281% of normal. The stock has performed in line with the market over the last nine months and has declined -6.3% during the last week.
Be the first to comment